Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
38,56 USD | -0,10% |
|
+0,26% | +4,05% |
10/07 | GSK : Deutsche Bank conferma il rating Buy | ZD |
08/07 | Uno studio rileva che il vaccino RSV di Pfizer non è legato a un rischio maggiore di nascite pre-termine | RE |
Attività
Numero di dipendenti: 70 212
Vendite per attività
GBP in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Commercial Operations
100,0
%
| 29 324 | 100,0 % | 30 328 | 100,0 % | +3,42% |
Vendite per regione
GBP in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
52,2
%
| 14 542 | 49,6 % | 15 820 | 52,2 % | +8,79% |
Rest of World
45,6
%
| 14 087 | 48,0 % | 13 815 | 45,6 % | -1,93% |
United Kingdom
2,3
%
| 695 | 2,4 % | 693 | 2,3 % | -0,29% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 55 | 01/05/10 |
Julie Brown
DFI | Director of Finance/CFO | 62 | 01/05/23 |
James Ford
CMP | Compliance Officer | - | 01/08/95 |
Amy Altshul
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 01/01/18 | |
Tony Wood
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/17 |
Hal Barron
BRD | Director/Board Member | 62 | 01/01/18 |
David Redfern
PRN | Corporate Officer/Principal | 57 | 01/01/94 |
Frannie DeFranco
PRN | Corporate Officer/Principal | - | 01/09/10 |
Claire Lund
PRN | Corporate Officer/Principal | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Julie Brown
DFI | Director of Finance/CFO | 62 | 01/05/23 |
Jonathan Symonds
CHM | Chairman | 66 | 01/09/19 |
Hal Barron
BRD | Director/Board Member | 62 | 01/01/18 |
Vishal Sikka
BRD | Director/Board Member | 57 | 18/07/22 |
Wendy Becker
BRD | Director/Board Member | 58 | 01/10/23 |
Charles Bancroft
BRD | Director/Board Member | 65 | 01/05/20 |
Anne Beal
BRD | Director/Board Member | 62 | 06/05/21 |
Emma Walmsley
CEO | Chief Executive Officer | 55 | 01/05/10 |
Director/Board Member | 66 | 01/09/22 | |
Jesse Goodman
BRD | Director/Board Member | 72 | 01/01/16 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 4 314 215 315 | 4 078 421 582 ( 94,53 %) | 169 171 155 ( 3,921 %) | 94,53 % |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
127 054 524 | 75.00% | 4 041 214 351 $ | |
HALEON PLC 4.22% | 385 320 110 | 4.22% | 1 571 331 555 $ |
263 029 794 | 82.59% | 135 946 949 $ | |
HALEON PAKISTAN LIMITED 85.79% | 100 423 259 | 85.79% | 107 304 261 $ |
VIR BIOTECHNOLOGY, INC. 6.28% | 8 550 954 | 6.28% | 76 103 491 $ |
WAVE LIFE SCIENCES LTD. 11.42% | 13 983 761 | 11.42% | 69 778 967 $ |
CUREVAC N.V. 7.40% | 16 591 937 | 7.40% | 56 412 586 $ |
GLAXOSMITHKLINE S.A.E 91.20% | 76 161 378 | 91.20% | 45 811 069 $ |
LYELL IMMUNOPHARMA, INC. 11.87% | 30 253 189 | 11.87% | 43 867 124 $ |
DONG-A ST CO., LTD. 8.17% | 722 016 | 8.17% | 32 992 954 $ |
Coordinate società
![Indirizzo GSK plc(GSK)](https://cdn.zonebourse.com/static/address/12835.png)
Società del gruppo
Nome | Categoria e settore |
---|---|
GlaxoSmithKline Asia Pvt Ltd.
![]() GlaxoSmithKline Asia Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Asia Pvt Ltd. is an Indian company that produces bacterial and virus vaccines and other pharmaceutical products. The company is based in Gurgaon, India. |
Pharmaceuticals: Major
|
GlaxoSmithKline GmbH & Co. KG
![]() GlaxoSmithKline GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline GmbH & Co. KG is a German pharmaceutical company. The company is based in Munich, Germany. The CEOs of the company are Jean-Bernard Siméon, Adrian Bauer. |
Pharmaceuticals: Major
|
Glaxosmithkline Investment Services Ltd.
![]() Glaxosmithkline Investment Services Ltd. Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Glaxosmithkline Investment Services Ltd. provides business support services. The company is based in Middlesex, UK and was founded in 2009. |
Miscellaneous Commercial Services
|
SmithKline Beecham (Cork) Ltd.
![]() SmithKline Beecham (Cork) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, SmithKline Beecham (Cork) Ltd. is an Irish pharmaceutical company that manufactures pharmaceutical products. The company is based in Carrigaline, Ireland. |
Pharmaceuticals: Major
|
GlaxoSmithKline Insurance Ltd.
| |
GlaxoSmithKline Trading Services Ltd.
![]() GlaxoSmithKline Trading Services Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Trading Services Ltd. is an Irish company that manufactures and wholesales pharmaceutical products. The company is based in Dublin, Ireland. |
Pharmaceuticals: Major
|
GSK Consumer Healthcare Capital US LLC
![]() GSK Consumer Healthcare Capital US LLC Medical/Nursing ServicesHealth Services Part of Haleon Plc, Haleon US Capital LLC is a company that provides healthcare services. Haleon US Capital LLC is based in Wilmington, DE. |
Medical/Nursing Services
|
GlaxoSmithKline Holdings (Ireland) Ltd.
![]() GlaxoSmithKline Holdings (Ireland) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, GlaxoSmithKline Holdings (Ireland) Ltd. provides financial management services. The company is based in Brentford, UK. Founded in 2014. |
Miscellaneous Commercial Services
|
GlaxoSmithKline Services Unlimited
![]() GlaxoSmithKline Services Unlimited Pharmaceuticals: MajorHealth Technology Glaxosmithkline Services Unlimited Ltd. develops, manufactures and markets pharmaceutical products. The company was incorporated on March 23, 1972 and is headquartered in Brentford, the United Kingdom. |
Pharmaceuticals: Major
|
Settore
Vendite per attività
Vendite per regione
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+61,22% | 846 Mrd | |
+38,98% | 628 Mrd | |
-4,66% | 360 Mrd | |
+16,77% | 322 Mrd | |
+8,50% | 297 Mrd | |
+14,13% | 240 Mrd | |
+17,83% | 223 Mrd | |
+3,11% | 224 Mrd | |
+11,68% | 173 Mrd |
- Borsa valori
- Azioni
- Azione GSK
- Azione GSK
- Società GSK plc